Granular corneal dystrophy: Difference between revisions
CSV import |
|||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Granular corneal dystrophy | |||
| image = [[File:Granular_corneal_dystrophy_type_I._Numerous_irregular_shaped_discrete_crumb-like_corneal_opacities.JPEG|250px]] | |||
| caption = Numerous irregular shaped discrete crumb-like corneal opacities | |||
| field = [[Ophthalmology]] | |||
| synonyms = Granular dystrophy, Groenouw type I | |||
| symptoms = [[Corneal opacity]], [[vision impairment]] | |||
| onset = Childhood | |||
| duration = Progressive | |||
| causes = Genetic mutation in the [[TGFBI]] gene | |||
| risks = Family history | |||
| diagnosis = [[Slit-lamp examination]], [[genetic testing]] | |||
| differential = [[Lattice corneal dystrophy]], [[macular corneal dystrophy]] | |||
| treatment = [[Phototherapeutic keratectomy]], [[corneal transplant]] | |||
| frequency = Rare | |||
}} | |||
'''Granular Corneal Dystrophy''' (GCD), also known as Groenouw type I dystrophy, is a rare, inherited eye disorder that primarily affects the [[cornea]], the clear, front surface of the eye. This condition is characterized by the accumulation of granular deposits within the cornea, leading to visual impairment. Granular corneal dystrophy is classified as a type of [[corneal dystrophy]], a group of genetic, progressive eye disorders that can affect the clarity and health of the cornea. | '''Granular Corneal Dystrophy''' (GCD), also known as Groenouw type I dystrophy, is a rare, inherited eye disorder that primarily affects the [[cornea]], the clear, front surface of the eye. This condition is characterized by the accumulation of granular deposits within the cornea, leading to visual impairment. Granular corneal dystrophy is classified as a type of [[corneal dystrophy]], a group of genetic, progressive eye disorders that can affect the clarity and health of the cornea. | ||
==Causes and Genetics== | ==Causes and Genetics== | ||
Granular corneal dystrophy is caused by mutations in the [[TGFBI]] (transforming growth factor, beta-induced) gene, located on chromosome 5q31. This gene is responsible for producing a protein that plays a crucial role in the development and maintenance of the cornea. Mutations in the TGFBI gene lead to the abnormal accumulation of protein in the cornea, forming granular deposits that can impair vision. The condition is inherited in an autosomal dominant manner, meaning only one copy of the altered gene is necessary to cause the disorder. | Granular corneal dystrophy is caused by mutations in the [[TGFBI]] (transforming growth factor, beta-induced) gene, located on chromosome 5q31. This gene is responsible for producing a protein that plays a crucial role in the development and maintenance of the cornea. Mutations in the TGFBI gene lead to the abnormal accumulation of protein in the cornea, forming granular deposits that can impair vision. The condition is inherited in an autosomal dominant manner, meaning only one copy of the altered gene is necessary to cause the disorder. | ||
==Symptoms== | ==Symptoms== | ||
The primary symptom of granular corneal dystrophy is the presence of granular, opaque deposits in the cornea. These deposits typically appear in the first or second decade of life and can progress, leading to: | The primary symptom of granular corneal dystrophy is the presence of granular, opaque deposits in the cornea. These deposits typically appear in the first or second decade of life and can progress, leading to: | ||
| Line 9: | Line 24: | ||
* Increased sensitivity to light ([[photophobia]]) | * Increased sensitivity to light ([[photophobia]]) | ||
* Foreign body sensation in the eye | * Foreign body sensation in the eye | ||
Symptoms can vary significantly in severity among affected individuals, and in some cases, vision may remain relatively unaffected until later in life. | Symptoms can vary significantly in severity among affected individuals, and in some cases, vision may remain relatively unaffected until later in life. | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of granular corneal dystrophy is primarily based on clinical examination, including a detailed patient history and visual inspection of the cornea using a slit-lamp microscope. Genetic testing can confirm the diagnosis by identifying mutations in the TGFBI gene. | Diagnosis of granular corneal dystrophy is primarily based on clinical examination, including a detailed patient history and visual inspection of the cornea using a slit-lamp microscope. Genetic testing can confirm the diagnosis by identifying mutations in the TGFBI gene. | ||
==Treatment== | ==Treatment== | ||
Treatment options for granular corneal dystrophy are aimed at managing symptoms and improving vision. In the early stages, visual impairment may be corrected with eyeglasses or contact lenses. As the disease progresses, more invasive treatments may be necessary, including: | Treatment options for granular corneal dystrophy are aimed at managing symptoms and improving vision. In the early stages, visual impairment may be corrected with eyeglasses or contact lenses. As the disease progresses, more invasive treatments may be necessary, including: | ||
* [[Laser therapy]], such as phototherapeutic keratectomy (PTK), to remove superficial corneal deposits | * [[Laser therapy]], such as phototherapeutic keratectomy (PTK), to remove superficial corneal deposits | ||
* [[Corneal transplantation]] in cases where vision is severely affected | * [[Corneal transplantation]] in cases where vision is severely affected | ||
==Prognosis== | ==Prognosis== | ||
The prognosis for individuals with granular corneal dystrophy varies. While the condition is progressive, the rate of progression and the degree of visual impairment can differ significantly among affected individuals. With appropriate management, most people with granular corneal dystrophy can maintain functional vision well into adulthood. | The prognosis for individuals with granular corneal dystrophy varies. While the condition is progressive, the rate of progression and the degree of visual impairment can differ significantly among affected individuals. With appropriate management, most people with granular corneal dystrophy can maintain functional vision well into adulthood. | ||
==See Also== | ==See Also== | ||
* [[Corneal dystrophy]] | * [[Corneal dystrophy]] | ||
| Line 28: | Line 38: | ||
* [[Corneal transplantation]] | * [[Corneal transplantation]] | ||
* [[Laser therapy]] | * [[Laser therapy]] | ||
[[Category:Eye diseases]] | [[Category:Eye diseases]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Corneal dystrophies]] | [[Category:Corneal dystrophies]] | ||
{{Medicine-stub}} | {{Medicine-stub}} | ||
Latest revision as of 20:27, 6 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Granular corneal dystrophy | |
|---|---|
| File:Granular corneal dystrophy type I. Numerous irregular shaped discrete crumb-like corneal opacities.JPEG | |
| Synonyms | Granular dystrophy, Groenouw type I |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Corneal opacity, vision impairment |
| Complications | N/A |
| Onset | Childhood |
| Duration | Progressive |
| Types | N/A |
| Causes | Genetic mutation in the TGFBI gene |
| Risks | Family history |
| Diagnosis | Slit-lamp examination, genetic testing |
| Differential diagnosis | Lattice corneal dystrophy, macular corneal dystrophy |
| Prevention | N/A |
| Treatment | Phototherapeutic keratectomy, corneal transplant |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | Rare |
| Deaths | N/A |
Granular Corneal Dystrophy (GCD), also known as Groenouw type I dystrophy, is a rare, inherited eye disorder that primarily affects the cornea, the clear, front surface of the eye. This condition is characterized by the accumulation of granular deposits within the cornea, leading to visual impairment. Granular corneal dystrophy is classified as a type of corneal dystrophy, a group of genetic, progressive eye disorders that can affect the clarity and health of the cornea.
Causes and Genetics[edit]
Granular corneal dystrophy is caused by mutations in the TGFBI (transforming growth factor, beta-induced) gene, located on chromosome 5q31. This gene is responsible for producing a protein that plays a crucial role in the development and maintenance of the cornea. Mutations in the TGFBI gene lead to the abnormal accumulation of protein in the cornea, forming granular deposits that can impair vision. The condition is inherited in an autosomal dominant manner, meaning only one copy of the altered gene is necessary to cause the disorder.
Symptoms[edit]
The primary symptom of granular corneal dystrophy is the presence of granular, opaque deposits in the cornea. These deposits typically appear in the first or second decade of life and can progress, leading to:
- Decreased visual acuity
- Increased sensitivity to light (photophobia)
- Foreign body sensation in the eye
Symptoms can vary significantly in severity among affected individuals, and in some cases, vision may remain relatively unaffected until later in life.
Diagnosis[edit]
Diagnosis of granular corneal dystrophy is primarily based on clinical examination, including a detailed patient history and visual inspection of the cornea using a slit-lamp microscope. Genetic testing can confirm the diagnosis by identifying mutations in the TGFBI gene.
Treatment[edit]
Treatment options for granular corneal dystrophy are aimed at managing symptoms and improving vision. In the early stages, visual impairment may be corrected with eyeglasses or contact lenses. As the disease progresses, more invasive treatments may be necessary, including:
- Laser therapy, such as phototherapeutic keratectomy (PTK), to remove superficial corneal deposits
- Corneal transplantation in cases where vision is severely affected
Prognosis[edit]
The prognosis for individuals with granular corneal dystrophy varies. While the condition is progressive, the rate of progression and the degree of visual impairment can differ significantly among affected individuals. With appropriate management, most people with granular corneal dystrophy can maintain functional vision well into adulthood.
See Also[edit]
This article is a medical stub. You can help WikiMD by expanding it!
